Whole-blood total mercury, present in 92.5% of subjects, but not urinary total (inorganic plus elemental) mercury, was dose-dependently associated with ALT elevation and suspected NAFLD. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.